DynaMesh^®-PRM

DynaMesh®-PRM and DynaMesh®-PRM visible implants are intended to be used as a suburethral sling for the surgical treatment of male stress urinary incontinence. The devices permanently reinforce the soft tissue of the pelvic floor and permanently relocates the posterior urethra.

DynaMesh®-PRMProduct RangeUse and PropertiesVideosFurther Product Information

The device must be inserted via an appropriate perineal approach and is positioned suburethrally under tension, in a transobturator tape position using the outside-in technique.

DynaMesh®-IST02
Diameter: 7 cm

DynaMesh®-IST03
Diameter: 5 cm

DynaMesh®-IST02 / DynaMesh®-IST03:
Instrument set consisting of two instruments for transobturator positioning using the outside-in technique.

DynaMesh®-PRM	04 cm x 03 cm	PV330453F1
DynaMesh®-PRM visible	04 cm x 03 cm	PV730453F1
	FX = X unit(s)/box (e.g. F3 = 3 unit(s)/box)

Product	DynaMesh®-PRM ⁽¹⁾ DynaMesh®-PRM visible ⁽²⁾
Surgical Treatment	Male Stress Urinary Incontinence (SUI)
Sugical Approach	Perineal
Surgical Technique	Male Sling TOT – Transobturator – Outside-In
Fixation	Suture / Synthetic Adhesive
Smooth Warp-Knitted Selvedges
Visible Technology	⁽¹⁾ / ⁽²⁾
Materials	– Polyvinylidene fluoride (PVDF) (CAS 24937-79-9) > 99% (w/w)^{(1) (2)} – Phthalocyanine green (CAS 1328-53-6) < 1% (w/w) ⁽¹⁾ – Triiron tetraoxide (CAS 1317-61-9) < 1% (w/w) ⁽²⁾
Polymer (Monofilament)	PVDF
Biocompatibility	[TR1]
Ageing resistance	[2^A, 5^VIT, 27^A, 52^VIT, 93^A, 101]

	Applicable
	Does not apply
[#]	Reference “#” (see “References”)
[TR#]	Internal test report (see “internal test report references”)
Limitations	“A” animal trial, “B” bench test, “VIT” in-vitro trial, “P” published results based on the analysis of human mesh explants, “PB” published results mainly based on bench tests

Videos: DynaMesh^®-PRM

Posted: 15. August 2024 | 0 comments

- Animation -
english

englishDynaMesh®-PRM visible - Animation: Surgical Treatment of Male Stress Urinary Incontinence

DynaMesh^® Catalogue

Posted: 19. March 2021 | 0 comments

Download as PDF (english)

Als pdf herunterladen (deutsch)

DynaMesh^®-LICHTENSTEIN

DynaMesh®-LICHTENSTEIN and DynaMesh®-LICHTENSTEIN visible implants are intended for the surgical treatment of inguinal hernias and permanently bridge and reinforce the soft tissue in the groin region in the area of the hernia defect.

DynaMesh®-LICHTENSTEINProduct RangeUse and PropertiesFurther Product Information

For example: inguinal hernia, left side

lichtenstein-detail

lichtenstein-elastische-sic

Varying Pore Size
The devices have areas with different pore sizes.

lichtenstein-tunnelbildung

Prefabricated Slit & Smooth Warp-Knitted Selvedges
The devices have a prefabricated slit with smooth warp-knitted selvedges, and they have tear propagation resistance [TR82].

lichtenstein-spezielle-wirk

Visibility & Handling
The colouring provides better intraoperative visibility and handling of the device.

[#]	Reference “#” (see “References”)
[TR#]	Internal test report (see “internal test report references”)
Limitations	“A” animal trial, “B” bench test, “VIT” in-vitro trial, “P” published results based on the analysis of human mesh explants, “PB” published results mainly based on bench tests

When selecting the mesh size, ensure sufficient overlap!

DynaMesh®-LICHTENSTEIN	06 cm x 11 cm	PV110611F1/F3/F5/F10
DynaMesh®-LICHTENSTEIN	7.5 cm x 15 cm	PV110715F1/F3/F5/F10
DynaMesh®-LICHTENSTEIN	10 cm x 15 cm	PV111015F1/F3/F5
DynaMesh®-LICHTENSTEIN visible	06 cm x 11 cm	PV170611F3/F10
DynaMesh®-LICHTENSTEIN visible	7.5 cm x 15 cm	PV170715F1/F3/F10
	FX = X unit(s)/box (e.g. F3 = 3 unit(s)/box)

Can be used both for the right and the left side.

Product	DynaMesh®-LICHTENSTEIN ⁽¹⁾ DynaMesh®-LICHTENSTEIN visible⁽²⁾
Surgical Treatment	Inguinal Hernias
Surgical Approach	Open
Surgical Technique	Lichtenstein
Mesh Position	Onlay (Anterior)
Fixation	Sutures / Tacks / Tissue Adhesives^*
Coloured Filaments	Green⁽¹⁾ / Black⁽²⁾
Smooth Warp-Knitted Selvedges
Visible Technology	⁽¹⁾/ ⁽²⁾
Materials	– Polyvinylidene fluoride (PVDF) (CAS 24937-79-9) > 99% (w/w) ^{(1) (2)} – Phthalocyanine green (CAS 1328-53-6) < 1% (w/w) ⁽¹⁾ – Triiron tetraoxide (CAS 1317-61-9) < 1% (w/w) ⁽²⁾
Polymer (Monofilament)	PVDF
Biocompatibility	[TR1]
Ageing Resistance	[2^A, 5^VIT, 27^A, 52^VIT, 93^A, 101]
Tear Propagation Resistance	[TR82]
Effective Porosity	High effective porosity reduces inflammation and the risk of excessive scar formation. [103^P, TR83]
Klinge’s Mesh Classification	Class 1a [102^P, TR83]
	^* Tissue adhesive can be used for fixation for direct or indirect inguinal hernias with a defect size of 1.5 cm to 3 cm (European Hernia Society Classification: M2 or L2).

	Applies to all product sizes
	Does not apply
[#]	Reference “#” (see “References”)
[TR#]	Internal test report (see “internal test report references”)
Limitations	“A” animal trial, “B” bench test, “VIT” in-vitro trial, “P” published results based on the analysis of human mesh explants, “PB” published results mainly based on bench tests

DynaMesh^® Catalogue

Posted: 19. March 2021 | 0 comments

Download as PDF (english)

Als pdf herunterladen (deutsch)

DynaMesh^®-CICAT

DynaMesh®-CICAT and DynaMesh®-CICAT visible implants are intended for the surgical treatment of epigastric hernias, umbilical or incisional hernias, and the prevention of incisional hernias, and permanently bridge and reinforce the soft tissue of the abdominal wall in the area of the abdominal wall defect.

DynaMesh®-CICATProduct RangeUse and PropertiesVideosFurther Product Information

Anti-Slip Surface
The devices have an anti-slip surface that ensures stable positioning of the mesh with reduced fixation compared to other devices available on the market. [132^PB, 133^PB, 134]

Dynamometric Positioning
For the correct dynamometric positioning of the device, ensure that the green or black marking strips are in a cranio-caudal orientation.

High Effective Porosity
The devices have a high effective porosity, which is known to reduce inflammation and the risk of excessive scar formation. [103^P, TR33, TR35]

The device must not be placed partially or completely intraperitoneally.

[#]	Reference “#”(see “References”)
[TR#]	Internal test report (see “internal test report references”)
Limitations	“A” animal trial, “B” bench test, “VIT” in-vitro trial, “P” published results based on the analysis of human mesh explants, “PB” published results mainly based on bench tests

When selecting and cutting the device, sufficient defect/scar overlap must be ensured to minimise the likelihood of the hernia recurring. With epigastric hernias and umbilical hernias, it is crucial to overlap the hernia orifice, whereas with incisional hernias it is crucial to overlap the scar tissue.

DynaMesh®-CICAT	d 10 cm round	PV090010F1/F3
DynaMesh®-CICAT	05 cm x 06 cm	PV090506F1/F5
DynaMesh®-CICAT	10 cm x 10 cm	PV091010F1/F3/F5
DynaMesh®-CICAT	10 cm x 15 cm	PV091015F5
DynaMesh®-CICAT	10 cm x 35 cm	PV091035F1/F2
DynaMesh®-CICAT	15 cm x 15 cm	PV091515F1/F3
DynaMesh®-CICAT	15 cm x 25 cm	PV091525F1/F2/F5
DynaMesh®-CICAT	15 cm x 30 cm	PV091530F1/F2/F5
DynaMesh®-CICAT	15 cm x 60 cm	PV091560F1
DynaMesh®-CICAT	18 cm x 40 cm	PV091840F2
DynaMesh®-CICAT	20 cm x 30 cm	PV092030F1/F2/F5
DynaMesh®-CICAT	27 cm x 15 cm	PV092715F1/F2
DynaMesh®-CICAT	30 cm x 30 cm	PV093030F1/F2
DynaMesh®-CICAT	30 cm x 45 cm	PV093045F1/F3
DynaMesh®-CICAT	40 cm x 20 cm	PV094020F1/F2
DynaMesh®-CICAT	45 cm x 60 cm	PV094560F1
DynaMesh®-CICAT visible	d 10 cm round	PV160010F3
DynaMesh®-CICAT visible	05 cm x 06 cm	PV160506F1/F5
DynaMesh®-CICAT visible	07 cm x 35 cm	PV160735F1/F5
DynaMesh®-CICAT visible	10 cm x 10 cm	PV161010F3
DynaMesh®-CICAT visible	10 cm x 35 cm	PV161035F2
DynaMesh®-CICAT visible	15 cm x 15 cm	PV161515F3
DynaMesh®-CICAT visible	15 cm x 25 cm	PV161525F2/F5
DynaMesh®-CICAT visible	15 cm x 30 cm	PV161530F2
DynaMesh®-CICAT visible	18 cm x 40 cm	PV161840F2
DynaMesh®-CICAT visible	20 cm x 30 cm	PV162030F1/F2/F5
DynaMesh®-CICAT visible	30 cm x 45 cm	PV163045F1/F3
DynaMesh®-CICAT visible	40 cm x 20 cm	PV164020F1
DynaMesh®-CICAT visible	45 cm x 60 cm	PV164560F1
	FX = X unit(s)/box (e.g. F3 = 3 unit(s)/box)
	size: laterolateral x craniocaudal

Product	DynaMesh®-CICAT ⁽¹⁾ DynaMesh®-CICAT visible ⁽²⁾
Surgical Treatment	Epigastric Hernias / Umbilical Hernias / Incisional Hernias Prevention: Incisional Hernia
Surgical Approach	Minimally Invasive / Open
Mesh Position	Extraperitoneal (onlay, sublay and/or preperitoneal)
Fixation	Sutures / Tacks / Tissue Adhesives
Marking Strips	Green ⁽¹⁾/ Black ⁽²⁾
Visible Technology	⁽¹⁾ / ⁽²⁾
Materials	– Polyvinylidene fluoride (PVDF) (CAS 24937-79-9) > 99% (w/w) ^{(1) (2)} – Phthalocyanine green (CAS 1328-53-6) < 1% (w/w) ⁽¹⁾ – Triiron tetraoxide (CAS 1317-61-9) < 1% (w/w) ⁽²⁾
Polymer (Monofilament)	PVDF
Biocompatibility	[TR1]
Ageing Resistance	[2^A, 5^VIT, 27^A, 52^VIT, 93^A, 101]
Dynamometric Properties	[TR38, 128^P, 129]
Tear Propagation Resistance	[TR31]
Anti-Slip Surface	[132^PB, 133^PB, 134]
Effective Porosity	High effective porosity reduces inflammation and the risk of excessive scar formation. [103^P, TR33, TR35]
Klinge’s Mesh Classification	Class 1a [102^P, TR33, TR35]
	DynaMesh®-CICAT implants must be placed extraperitoneally in onlay, sublay and/or preperitoneal mesh position.

	Applies to all product sizes
	Does not apply
[#]	Reference “#” (see “References”)
[TR#]	Internal test report (see “internal test report references”)
Limitations	“A” animal trial, “B” bench test, “VIT” in-vitro trial, “P” published results based on the analysis of human mesh explants, “PB” published results mainly based on bench tests